<VariationArchive RecordType="classified" VariationID="995916" VariationName="NM_181458.4(PAX3):c.925dup (p.Glu309fs)" VariationType="Duplication" Accession="VCV000995916" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2021-01-30" MostRecentSubmission="2021-01-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="983616" VariationID="995916">
      <GeneList>
        <Gene Symbol="PAX3" FullName="paired box 3" GeneID="5077" HGNC_ID="HGNC:8617" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="222199887" stop="222298998" display_start="222199887" display_stop="222298998" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="223064605" stop="223163714" display_start="223064605" display_stop="223163714" Strand="-" />
          </Location>
          <OMIM>606597</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PAX3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_181458.4(PAX3):c.925dup (p.Glu309fs)</Name>
      <CanonicalSPDI>NC_000002.12:222221254:CC:CCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q36.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="222221254" stop="222221255" display_start="222221254" display_stop="222221255" variantLength="1" positionVCF="222221254" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="223085973" stop="223085974" display_start="223085973" display_stop="223085974" variantLength="1" positionVCF="223085973" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>E308fs</ProteinChange>
      <ProteinChange>E309fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.223085975dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.223085975dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.222221256dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.222221256dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011632.1" sequenceAccession="NG_011632" sequenceVersion="1" change="g.82727dup">
            <Expression>NG_011632.1:g.82727dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127366.3" sequenceAccession="NM_001127366" sequenceVersion="3" change="c.922dup">
            <Expression>NM_001127366.3:c.922dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120838.1" sequenceAccession="NP_001120838" sequenceVersion="1" change="p.Glu308fs">
            <Expression>NP_001120838.1:p.Glu308fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181457.4" sequenceAccession="NM_181457" sequenceVersion="4" change="c.925dup">
            <Expression>NM_181457.4:c.925dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852122.1" sequenceAccession="NP_852122" sequenceVersion="1" change="p.Glu309fs">
            <Expression>NP_852122.1:p.Glu309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181458.4" sequenceAccession="NM_181458" sequenceVersion="4" change="c.925dup" MANESelect="true">
            <Expression>NM_181458.4:c.925dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852123.1" sequenceAccession="NP_852123" sequenceVersion="1" change="p.Glu309fs">
            <Expression>NP_852123.1:p.Glu309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181459.4" sequenceAccession="NM_181459" sequenceVersion="4" change="c.925dup">
            <Expression>NM_181459.4:c.925dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852124.1" sequenceAccession="NP_852124" sequenceVersion="1" change="p.Glu309fs">
            <Expression>NP_852124.1:p.Glu309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181460.4" sequenceAccession="NM_181460" sequenceVersion="4" change="c.925dup">
            <Expression>NM_181460.4:c.925dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852125.1" sequenceAccession="NP_852125" sequenceVersion="1" change="p.Glu309fs">
            <Expression>NP_852125.1:p.Glu309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181461.4" sequenceAccession="NM_181461" sequenceVersion="4" change="c.925dup">
            <Expression>NM_181461.4:c.925dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852126.1" sequenceAccession="NP_852126" sequenceVersion="1" change="p.Glu309fs">
            <Expression>NP_852126.1:p.Glu309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1692180906" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_181458.4(PAX3):c.925dup (p.Glu309fs) AND Waardenburg syndrome type 1" Accession="RCV001290149" Version="1">
        <ClassifiedConditionList TraitSetID="1162">
          <ClassifiedCondition DB="MedGen" ID="C1847800">Waardenburg syndrome type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-01-30" MostRecentSubmission="2021-01-30">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1162" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4496" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Waardenburg's syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WAARDENBURG SYNDROME WITH DYSTOPIA CANTHORUM</ElementValue>
                <XRef Type="MIM" ID="193500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Waardenburg syndrome type 1</ElementValue>
                <XRef ID="Waardenburg+syndrome+type+1/7424" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008670" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WS1</ElementValue>
                <XRef Type="MIM" ID="193500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PAX3</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Waardenburg syndrome type I (WS1) is an auditory-pigmentary disorder comprising congenital sensorineural hearing loss and pigmentary disturbances of the iris, hair, and skin, along with dystopia canthorum (lateral displacement of the inner canthi). The hearing loss in WS1, observed in approximately 60% of affected individuals, is congenital, typically non-progressive, either unilateral or bilateral, and sensorineural. Most commonly, hearing loss in WS1 is bilateral and profound (&gt;100 dB). The majority of individuals with WS1 have either a white forelock or early graying of the scalp hair before age 30 years. The classic white forelock observed in approximately 45% of individuals is the most common hair pigmentation anomaly seen in WS1. Affected individuals may have complete heterochromia iridium, partial/segmental heterochromia, or hypoplastic or brilliant blue irides. Congenital leukoderma is frequently seen on the face, trunk, or limbs.</Attribute>
                <XRef ID="NBK1531" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5519" />
                <XRef ID="5519" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301703</ID>
                <ID Source="BookShelf">NBK1531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24651602</ID>
              </Citation>
              <XRef ID="894" DB="Orphanet" />
              <XRef ID="C1847800" DB="MedGen" />
              <XRef ID="MONDO:0008670" DB="MONDO" />
              <XRef Type="MIM" ID="193500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2913998" SubmissionDate="2020-12-17" DateLastUpdated="2021-01-30" DateCreated="2021-01-30">
        <ClinVarSubmissionID localKey="NM_001127366.2:c.922dupG|OMIM:193500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001478205" DateUpdated="2021-01-30" DateCreated="2021-01-30" Type="SCV" Version="1" SubmitterName="Genetic Testing Center for Deafness, Department of Otolaryngology Head &amp; Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital" OrgID="506993" OrganizationCategory="laboratory" OrgAbbreviation="DGTC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAX3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001127366.2:c.922dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="193500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8754818</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2913998" TraitType="Disease" MappingType="XRef" MappingValue="193500" MappingRef="OMIM">
        <MedGen CUI="C1847800" Name="Waardenburg syndrome type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

